Advertisement

Ads Placeholder
Loading...

Blue Jet Healthcare Limited

BLUEJET.BOBSE
Healthcare
Biotechnology
356.85
5.85(1.67%)
Indian Market opens in 34h 46m

Blue Jet Healthcare Limited Fundamental Analysis

Blue Jet Healthcare Limited (BLUEJET.BO) shows strong financial fundamentals with a PE ratio of 21.12, profit margin of 27.88%, and ROE of 26.41%. The company generates $10.5B in annual revenue with strong year-over-year growth of 45.00%.

Key Strengths

ROE26.41%
Operating Margin32.31%
PEG Ratio-1.27
Current Ratio4.11

Areas of Concern

No major concerns flagged.
We analyze BLUEJET.BO's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 91.9/100 based on profitability, valuation, growth, and balance sheet metrics. The A grade reflects excellent fundamentals and strong overall stability.

Fundamental Health Score

A
91.9/100

We analyze BLUEJET.BO's fundamental strength across five key dimensions:

Efficiency Score

Excellent

BLUEJET.BO demonstrates superior asset utilization.

ROA > 10%
19.22%

Valuation Score

Excellent

BLUEJET.BO trades at attractive valuation levels.

PE < 25
21.12
PEG Ratio < 2
-1.27

Growth Score

Excellent

BLUEJET.BO delivers strong and consistent growth momentum.

Revenue Growth > 5%
45.00%
EPS Growth > 10%
86.33%

Financial Health Score

Excellent

BLUEJET.BO maintains a strong and stable balance sheet.

Debt/Equity < 1
0.02
Current Ratio > 1
4.11

Profitability Score

Excellent

BLUEJET.BO achieves industry-leading margins.

ROE > 15%
26.41%
Net Margin ≥ 15%
27.88%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is BLUEJET.BO Expensive or Cheap?

P/E Ratio

BLUEJET.BO trades at 21.12 times earnings. This indicates a fair valuation.

21.12

PEG Ratio

When adjusting for growth, BLUEJET.BO's PEG of -1.27 indicates potential undervaluation.

-1.27

Price to Book

The market values Blue Jet Healthcare Limited at 4.94 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

4.94

EV/EBITDA

Enterprise value stands at 16.16 times EBITDA. This signals the market has high growth expectations.

16.16

How Well Does BLUEJET.BO Make Money?

Net Profit Margin

For every $100 in sales, Blue Jet Healthcare Limited keeps $27.88 as profit after all expenses.

27.88%

Operating Margin

Core operations generate 32.31 in profit for every $100 in revenue, before interest and taxes.

32.31%

ROE

Management delivers $26.41 in profit for every $100 of shareholder equity.

26.41%

ROA

Blue Jet Healthcare Limited generates $19.22 in profit for every $100 in assets, demonstrating efficient asset deployment.

19.22%

Following the Money - Real Cash Generation

Operating Cash Flow

Blue Jet Healthcare Limited produces operating cash flow of $2.07B, showing steady but balanced cash generation.

$2.07B

Free Cash Flow

Blue Jet Healthcare Limited produces free cash flow of $817.22M, offering steady but limited capital for shareholder returns and expansion.

$817.22M

FCF Per Share

Each share generates $4.71 in free cash annually.

$4.71

FCF Yield

BLUEJET.BO converts 1.32% of its market value into free cash.

1.32%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

21.12

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-1.27

vs 25 benchmark

P/B Ratio

Price to book value ratio

4.94

vs 25 benchmark

P/S Ratio

Price to sales ratio

5.89

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.02

vs 25 benchmark

Current Ratio

Current assets to current liabilities

4.11

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.26

vs 25 benchmark

ROA

Return on assets percentage

0.19

vs 25 benchmark

ROCE

Return on capital employed

0.26

vs 25 benchmark

How BLUEJET.BO Stacks Against Its Sector Peers

MetricBLUEJET.BO ValueSector AveragePerformance
P/E Ratio21.1228.45 Better (Cheaper)
ROE26.41%763.00% Weak
Net Margin27.88%-45265.00% (disorted) Strong
Debt/Equity0.020.34 Strong (Low Leverage)
Current Ratio4.112795.60 Strong Liquidity
ROA19.22%-16588.00% (disorted) Strong

BLUEJET.BO outperforms its industry in 5 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Blue Jet Healthcare Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

91.33%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

110.66%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

-62.72%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ